With no upgradation plan, several small drug companies may shut operations

Many small pharma companies in India may shut down. They did not meet the deadline for upgrading facilities. This is as per new Good Manufacturing Practices. Only 1,700 out of 6,000 units submitted upgrade plans. Closures could lead to job losses. There are also concerns about potential drug shortages and price increases. The government may initiate audits and regulatory actions.